GenScript Corp.

GenScript Corp.

GenScript Corp.

Overview
Date Founded

2002

Headquarters

860 Centennial Avenue,Piscataway, NJ 08854

Type of Company

Private

Employees (Worldwide)

1,001 - 5,000

Industries

Biotechnology
Holding Companies
Pharmaceuticals

Company Description

GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ.

Website

http://www.genscript.com

Contact Data
Trying to get in touch with decision makers at GenScript Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
PR Newswire
January 6, 2021
Global CRISPR Technology Market Report 2020: COVID-19 Growth and Change - Market is Expected to Recover to Reach $1.55 Billion in 2023 - Forecast to 2030
Business Wire
December 30, 2020
Global Research Antibodies and Reagents Market Report 2020-2030: COVID-19 Growth and Change - Market is Expected to Stabilize and Reach $13.19 Billion in 2023 - ResearchAndMarkets.com
Business Wire
November 9, 2020
Legend Biotech Announces Leadership Transition; Ye (Sally) Wang Appointed Chairwoman of the Board; Ying Huang Named CEO
SNL Financial
September 23, 2020
Legend Biotech appoints interim CEO
PR Newswire
September 15, 2020
Innatoss Laboratories Launches Neutralizing Antibody Public Testing Service for SARS-CoV-2 in Europe using GenScript's cPass™ kit; cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Gene Gamble

Owner

Frank Zhang

Chairman, Chief Executive Officer & Executive Director

Larry Wang

President

Sally Wang

Chief Operating Officer & Executive Director

Louisa Huo

General Manager

Bunichi Kuruma

Innovation Partner

Rita Tsai

Innovation Partner

Bhama Parimoo

Innovation Partner

Ilgar Abbaszade

Head of Marketing & Sales

Tang Yixin

Director of Advertising

Board of Directors
Frank Zhang

Chairman, Chief Executive Officer & Executive Director at GenScript Corp.

James Huang

Vice President-Corporate Development at OriGene Technologies, Inc.

Guo Hong Xin

Executive Director at Jiangsu Sunpower Petrochemical Engineering Co. Ltd.

Yi Ping Li

Co-Founder & Chief Executive Officer at JW Therapeutics (Shanghai) Co., Ltd.

Zhang Min

Executive Vice Chairman of the Board at Huazhu Group Ltd.

Zu Mian Dai

Former Secretary at Hisense Home Appliances Group Co., Ltd.

Yue Xin Pan

Director & Partner at Shanghai Ridingsheng Equity Investment Services Co., Ltd.

Lu Quan Wang

President at Nanjing GenScript Co., Ltd.

Trending People
3M Innovative Properties Co.
3M Innovative Properties Assigned Patent for Halogen, Polyhalide Mediated Phenol... - Targeted News Service
US Defense Logistics Agency
ISSPRO Wins $250,000 Federal Contract - Targeted News Service
Pfizer, Inc.
Senior doctors attack decision to make people wait 12 weeks for second dose of P... - The Independent UK
United States Department of Veterans Affairs
ALL AMERICAN CONTRACTING SOLUTIONS Wins $24,910 Federal Contract - Targeted News Service
Atlanta Braves, Inc.
SPORTS; RIP to Hammerin' Hank: He had all of the tools - Los Angeles Times
Trending Organizations
3M Innovative Properties Co.
3M Innovative Properties Assigned Patent for Halogen, Polyhalide Mediated Phenol... - Targeted News Service
US Defense Logistics Agency
ISSPRO Wins $250,000 Federal Contract - Targeted News Service
Pfizer, Inc.
Senior doctors attack decision to make people wait 12 weeks for second dose of P... - The Independent UK
United States Department of Veterans Affairs
ALL AMERICAN CONTRACTING SOLUTIONS Wins $24,910 Federal Contract - Targeted News Service
Atlanta Braves, Inc.
SPORTS; RIP to Hammerin' Hank: He had all of the tools - Los Angeles Times
Paths to GenScript Corp.
Potential Connections via
Relationship Science
You
GenScript Corp.
Recent Transactions
Details Hidden

Nanjing Bestzyme Bioengineering Co., Ltd., GenScript Corp. purchase Jinan Nornoon Biological Engineering Co., Ltd.

Clients
Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Investments
Details Hidden
Genscript Biotech Corp.

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by GenScript Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of GenScript Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and GenScript Corp..